Fusion Pharmaceuticals Inc.

5.75 USD
-0.07 (-1.20%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Fusion Pharmaceuticals Inc. stock is up 45.94% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 December’s closed higher than November. In the last 1 Unusual Options Trades, there were 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
25 Oct 15:58 17 May, 2024 2.50 CALL 256 13

About Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc. focuses on developing radiopharmaceuticals as precision medicines. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor.